-
1
-
-
0037121270
-
Antimicrobial resistance in staphylococci from canine pyoderma: a prospective study of first-time and recurrent cases in Sweden
-
Holm BR, Petersson U, Morner A et al. Antimicrobial resistance in staphylococci from canine pyoderma: a prospective study of first-time and recurrent cases in Sweden. The Veterinary Record 2002; 151: 600-5.
-
(2002)
The Veterinary Record
, vol.151
, pp. 600-605
-
-
Holm, B.R.1
Petersson, U.2
Morner, A.3
-
2
-
-
0027461995
-
A comparison of lincomycin hydrochloride and clindamycin hydrochloride in the treatment of superficial pyoderma in dogs
-
Harvey RG, Noble WC, Ferguson EA. A comparison of lincomycin hydrochloride and clindamycin hydrochloride in the treatment of superficial pyoderma in dogs. The Veterinary Record 1993; 132: 351-3.
-
(1993)
The Veterinary Record
, vol.132
, pp. 351-353
-
-
Harvey, R.G.1
Noble, W.C.2
Ferguson, E.A.3
-
3
-
-
0036712059
-
Frequency of isolation and antimicrobial susceptibility patterns of Staphylococcus intermedius and Pseudomonas aeruginosa isolates from canine skin and ear samples over a 6-year period (1992-1997)
-
Petersen AD, Walker RD, Bowman MM et al. Frequency of isolation and antimicrobial susceptibility patterns of Staphylococcus intermedius and Pseudomonas aeruginosa isolates from canine skin and ear samples over a 6-year period (1992-1997). Journal of the American Animal Hospital Association 2002; 38: 407-13.
-
(2002)
Journal of the American Animal Hospital Association
, vol.38
, pp. 407-413
-
-
Petersen, A.D.1
Walker, R.D.2
Bowman, M.M.3
-
4
-
-
18944376981
-
Investigations into the basis of chloramphenicol and tetracycline resistance in Staphylococcus intermedius isolates from cases of pyoderma in dogs
-
Kim TJ, Na YR, Lee JI. Investigations into the basis of chloramphenicol and tetracycline resistance in Staphylococcus intermedius isolates from cases of pyoderma in dogs. Journal of Veterinary Medicine. B. Infectious Diseases and Veterinary Public Health 2005; 52: 119-24.
-
(2005)
Journal of Veterinary Medicine. B. Infectious Diseases and Veterinary Public Health
, vol.52
, pp. 119-124
-
-
Kim, T.J.1
Na, Y.R.2
Lee, J.I.3
-
6
-
-
33845234226
-
Species distribution and properties of staphylococci from canine dermatitis
-
Hauschild T, Wójcik A. Species distribution and properties of staphylococci from canine dermatitis. Research in Veterinary Science 2007; 82: 1-6.
-
(2007)
Research in Veterinary Science
, vol.82
, pp. 1-6
-
-
Hauschild, T.1
Wójcik, A.2
-
7
-
-
34548662622
-
Reclassification of phenotypically identified Staphylococcus intermedius strains
-
Sasaki T, Kikuchi K, Tanaka Y et al. Reclassification of phenotypically identified Staphylococcus intermedius strains. Journal of Clinical Microbiology 2007; 45: 2770-8.
-
(2007)
Journal of Clinical Microbiology
, vol.45
, pp. 2770-2778
-
-
Sasaki, T.1
Kikuchi, K.2
Tanaka, Y.3
-
8
-
-
36749006068
-
Population genetic structure of the Staphylococcus intermedius group: insights into agr diversification and the emergence of methicillin-resistant strains
-
Bannoehr J, Ben Zakour NL, Waller AS et al. Population genetic structure of the Staphylococcus intermedius group: insights into agr diversification and the emergence of methicillin-resistant strains. Journal of Bacteriology 2007; 189: 8685-92.
-
(2007)
Journal of Bacteriology
, vol.189
, pp. 8685-8692
-
-
Bannoehr, J.1
Ben Zakour, N.L.2
Waller, A.S.3
-
9
-
-
77956475573
-
In vitro antimicrobial efficacy of β-defensin 3 against Staphylococcus pseudintermedius isolates from healthy and atopic canine skin
-
Fazakerley J, Crossley J, McEwan N et al. In vitro antimicrobial efficacy of β-defensin 3 against Staphylococcus pseudintermedius isolates from healthy and atopic canine skin. Veterinary Dermatology 2010; 21: 463-8.
-
(2010)
Veterinary Dermatology
, vol.21
, pp. 463-468
-
-
Fazakerley, J.1
Crossley, J.2
McEwan, N.3
-
10
-
-
73149119560
-
The Staphylococcus intermedius group of bacterial pathogens: species re-classification, pathogenesis and the emergence of meticillin resistance
-
Fitzgerald JR. The Staphylococcus intermedius group of bacterial pathogens: species re-classification, pathogenesis and the emergence of meticillin resistance. Veterinary Dermatology 2009; 20: 490-5.
-
(2009)
Veterinary Dermatology
, vol.20
, pp. 490-495
-
-
Fitzgerald, J.R.1
-
11
-
-
0001944103
-
Bacterial skin diseases
-
6th edn. Philadelphia, PA: W.B. Saunders
-
Scott DW, Miller WH, Griffin CE. Bacterial skin diseases. In: Muller and Kirk's Small Animal Dermatology, 6th edn. Philadelphia, PA: W.B. Saunders, 2001: 274-335.
-
(2001)
Muller and Kirk's Small Animal Dermatology
, pp. 274-335
-
-
Scott, D.W.1
Miller, W.H.2
Griffin, C.E.3
-
13
-
-
0035159876
-
Efficacy of once-daily clindamycin hydrochloride in the treatment of superficial bacterial pyoderma in dogs
-
Bloom PB, Rosser EJ. Efficacy of once-daily clindamycin hydrochloride in the treatment of superficial bacterial pyoderma in dogs. Journal of the American Animal Hospital Association 2001; 37: 537-42.
-
(2001)
Journal of the American Animal Hospital Association
, vol.37
, pp. 537-542
-
-
Bloom, P.B.1
Rosser, E.J.2
-
14
-
-
0032411424
-
Efficacy of clindamycin hydrochloride capsules for the treatment of deep pyoderma due to Staphylococcus intermedius infection in dogs
-
Scott DW, Beningo KE, Miller WH et al. Efficacy of clindamycin hydrochloride capsules for the treatment of deep pyoderma due to Staphylococcus intermedius infection in dogs. Canadian Veterinary Journal 1998; 39: 753-6.
-
(1998)
Canadian Veterinary Journal
, vol.39
, pp. 753-756
-
-
Scott, D.W.1
Beningo, K.E.2
Miller, W.H.3
-
15
-
-
14644440905
-
Antimicrobial drug susceptibility of Staphylococcus intermedius clinical isolates from canine pyoderma
-
Ganiere JP, Medaille C, Mangion C. Antimicrobial drug susceptibility of Staphylococcus intermedius clinical isolates from canine pyoderma. Journal of Veterinary Medicine Series B 2005; 52: 25-31.
-
(2005)
Journal of Veterinary Medicine Series B
, vol.52
, pp. 25-31
-
-
Ganiere, J.P.1
Medaille, C.2
Mangion, C.3
-
16
-
-
0031980604
-
Epidemiosurveillance of antimicrobial compound resistance of Staphylococcus intermedius clinical isolates from canine pyodermas
-
Pellerin JL, Bourdeau P, Sebbag H et al. Epidemiosurveillance of antimicrobial compound resistance of Staphylococcus intermedius clinical isolates from canine pyodermas. Comparative Immunology Microbiology and Infectious Diseases 1998; 21: 115-33.
-
(1998)
Comparative Immunology Microbiology and Infectious Diseases
, vol.21
, pp. 115-133
-
-
Pellerin, J.L.1
Bourdeau, P.2
Sebbag, H.3
-
17
-
-
0029868102
-
The antimicrobial susceptibility of Staphylococcus species isolated from canine dermatitis
-
Kruse H, Hofshagen M, Thoresen SI et al. The antimicrobial susceptibility of Staphylococcus species isolated from canine dermatitis. Veterinary Research Communications 1996; 20: 205-14.
-
(1996)
Veterinary Research Communications
, vol.20
, pp. 205-214
-
-
Kruse, H.1
Hofshagen, M.2
Thoresen, S.I.3
-
18
-
-
0022570118
-
Frequency and antimicrobial susceptibility of Staphylococus species isolated from canine pyodermas
-
Medleau L, Long RE, Brown J et al. Frequency and antimicrobial susceptibility of Staphylococus species isolated from canine pyodermas. American Journal of Veterinary Research 1986; 47: 229-31.
-
(1986)
American Journal of Veterinary Research
, vol.47
, pp. 229-231
-
-
Medleau, L.1
Long, R.E.2
Brown, J.3
-
19
-
-
84995123571
-
Antibiotic resistance in Staphylococcus intermedius isolated from cases of pyoderma in the dog
-
Noble WC, Kent LE. Antibiotic resistance in Staphylococcus intermedius isolated from cases of pyoderma in the dog. Veterinary Dermatology 1992; 3: 71-4.
-
(1992)
Veterinary Dermatology
, vol.3
, pp. 71-74
-
-
Noble, W.C.1
Kent, L.E.2
-
20
-
-
0006990593
-
Kinetics of antibacterial activity after administration of enrofloxacin in dog serum and skin: in vitro susceptibility of field isolates
-
Stegemann M, Heukamp U, Scheer M et al. Kinetics of antibacterial activity after administration of enrofloxacin in dog serum and skin: in vitro susceptibility of field isolates. Compendium of Continuing Education for the Practicing Veterinarian 1996; 18(Supplement 1): 30-4.
-
(1996)
Compendium of Continuing Education for the Practicing Veterinarian
, vol.18
, Issue.SUPPLEMENT 1
, pp. 30-34
-
-
Stegemann, M.1
Heukamp, U.2
Scheer, M.3
-
22
-
-
0033549353
-
Clindamycin hydrochloride and clavulanate-amoxycillin in the treatment of canine superficial pyoderma
-
Littlewood JD, Lakhani KH, Paterson S et al. Clindamycin hydrochloride and clavulanate-amoxycillin in the treatment of canine superficial pyoderma. The Veterinary Record 1999; 144: 662-5.
-
(1999)
The Veterinary Record
, vol.144
, pp. 662-665
-
-
Littlewood, J.D.1
Lakhani, K.H.2
Paterson, S.3
-
24
-
-
0000722192
-
Noncompartmental analysis based on statistical moment theory
-
New York: Marcel Dekker Inc.
-
Gibaldi M, Perrier D. Noncompartmental analysis based on statistical moment theory. In: Pharmacokinetics. New York: Marcel Dekker Inc., 1982: 409-24.
-
(1982)
Pharmacokinetics
, pp. 409-424
-
-
Gibaldi, M.1
Perrier, D.2
-
26
-
-
0009996427
-
Factors affecting drug disposition and extrapolation of dosing regimens
-
Philadelphia, PA: W.B. Saunders
-
Boothe DM. Factors affecting drug disposition and extrapolation of dosing regimens. In: Small Animal Clinical Pharmacology and Therapeutics. Philadelphia, PA: W.B. Saunders, 2001: 18-40.
-
(2001)
Small Animal Clinical Pharmacology and Therapeutics
, pp. 18-40
-
-
Boothe, D.M.1
-
29
-
-
27844478779
-
Clindamycin bioavailability and pharmacokinetics following oral administration of clindamycin hydrochloride capsules in dogs
-
Batzias GC, Delis GA, Athanasiou LV. Clindamycin bioavailability and pharmacokinetics following oral administration of clindamycin hydrochloride capsules in dogs. The Veterinary Journal 2005; 170: 339-45.
-
(2005)
The Veterinary Journal
, vol.170
, pp. 339-345
-
-
Batzias, G.C.1
Delis, G.A.2
Athanasiou, L.V.3
-
30
-
-
0032863486
-
Pharmacokinetics of clindamycin HCl administered intravenously, intramuscularly and subcutaneously to dogs
-
Lavy E, Ziv G, Shem-Tov M et al. Pharmacokinetics of clindamycin HCl administered intravenously, intramuscularly and subcutaneously to dogs. Journal of Veterinary Pharmacology and Therapeutics 1999; 22: 261-5.
-
(1999)
Journal of Veterinary Pharmacology and Therapeutics
, vol.22
, pp. 261-265
-
-
Lavy, E.1
Ziv, G.2
Shem-Tov, M.3
-
31
-
-
27844517953
-
Oral absorption, bioavailability and tolerance study of clindamycin gel 3% in dogs
-
on CD Rom.
-
Lavy E, Shem-Tov M, Orbach A. Oral absorption, bioavailability and tolerance study of clindamycin gel 3% in dogs. Journal of Veterinary Pharmacology and Therapeutics 2000; 23 (Supplement 1): on CD Rom.
-
(2000)
Journal of Veterinary Pharmacology and Therapeutics
, vol.23
, Issue.SUPPLEMENT 1
-
-
Lavy, E.1
Shem-Tov, M.2
Orbach, A.3
-
32
-
-
80052554448
-
-
A retrospective analysis of clindamycin dosage regimens in dogs. Upjohn Technical Report 1977; no. 7254/77/7261/001: 17 November 1977.
-
Weber DJ. A retrospective analysis of clindamycin dosage regimens in dogs. Upjohn Technical Report 1977; no. 7254/77/7261/001: 17 November 1977.
-
-
-
Weber, D.J.1
-
33
-
-
80052521394
-
-
Clindamycin bioactivity following a multidose oral administration of Cleosin in dogs. Upjohn Technical Report 1978; no. 7254/78/7261/002: 16 March 1978.
-
Weber DJ, Barbiers AR, Henke CL. Clindamycin bioactivity following a multidose oral administration of Cleosin in dogs. Upjohn Technical Report 1978; no. 7254/78/7261/002: 16 March 1978.
-
-
-
Weber, D.J.1
Barbiers, A.R.2
Henke, C.L.3
-
34
-
-
0027066912
-
Pharmacokinetics of clindamycin phosphate in dogs after single intravenous and intramuscular administrations
-
Budsberg SC, Kemp DT, Wolski N. Pharmacokinetics of clindamycin phosphate in dogs after single intravenous and intramuscular administrations. American Journal of Veterinary Research 1992; 53: 2333-6.
-
(1992)
American Journal of Veterinary Research
, vol.53
, pp. 2333-2336
-
-
Budsberg, S.C.1
Kemp, D.T.2
Wolski, N.3
-
36
-
-
0036671104
-
Determination of clindamycin in animal plasma by high-performance liquid chromatography combined with electrospray ionization mass spectrometry
-
Cherlet M, Croubels S, De Backer P. Determination of clindamycin in animal plasma by high-performance liquid chromatography combined with electrospray ionization mass spectrometry. Journal of Mass Spectrometry 2002; 37: 848-53.
-
(2002)
Journal of Mass Spectrometry
, vol.37
, pp. 848-853
-
-
Cherlet, M.1
Croubels, S.2
De Backer, P.3
-
37
-
-
0037636484
-
In vitro metabolism of clindamycin in human liver and intestinal microsomes
-
Wynalda MA, Hutzler JM, Koets MD et al. In vitro metabolism of clindamycin in human liver and intestinal microsomes. Drug Metabolism and Disposition 2003; 31: 878-87.
-
(2003)
Drug Metabolism and Disposition
, vol.31
, pp. 878-887
-
-
Wynalda, M.A.1
Hutzler, J.M.2
Koets, M.D.3
-
38
-
-
0015818152
-
Metabolism of clindamycin. II. Urinary excretion products of clindamycin in rat and dog
-
Sun FF. Metabolism of clindamycin. II. Urinary excretion products of clindamycin in rat and dog. Journal of Pharmaceutical Sciences 1973; 62: 1657-62.
-
(1973)
Journal of Pharmaceutical Sciences
, vol.62
, pp. 1657-1662
-
-
Sun, F.F.1
-
39
-
-
52949101819
-
The pharmacokinetic-pharmacodynamic (PK/PD) relationship of antimicrobial agents
-
Giguere S, Prescott JF, Baggot JD, eds., 4th edn. Ames, IA: Blackwell Publishing
-
Martinez M, Toutain PL, Walker RD. The pharmacokinetic-pharmacodynamic (PK/PD) relationship of antimicrobial agents. In: Giguere S, Prescott JF, Baggot JD et al., eds. Antimicrobial Therapy in Veterinary Medicine, 4th edn. Ames, IA: Blackwell Publishing, 2006: 81-106.
-
(2006)
Antimicrobial Therapy in Veterinary Medicine
, pp. 81-106
-
-
Martinez, M.1
Toutain, P.L.2
Walker, R.D.3
-
40
-
-
0031036967
-
Bactericidal activity of low-dose clindamycin administered at 8- and 12-hour intervals against Staphylococcus aureus, Streptococcus pneumoniae, and Bacteroides fragilis
-
Klepser ME, Nicolau DP, Quintiliani R et al. Bactericidal activity of low-dose clindamycin administered at 8- and 12-hour intervals against Staphylococcus aureus, Streptococcus pneumoniae, and Bacteroides fragilis. Antimicrobial Agents and Chemotherapy 1997; 41: 630-5.
-
(1997)
Antimicrobial Agents and Chemotherapy
, vol.41
, pp. 630-635
-
-
Klepser, M.E.1
Nicolau, D.P.2
Quintiliani, R.3
-
41
-
-
0036226169
-
Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations
-
Liu P, Müller M, Derendorf H. Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations. International Journal of Antimicrobial Agents 2002; 19: 285-90.
-
(2002)
International Journal of Antimicrobial Agents
, vol.19
, pp. 285-290
-
-
Liu, P.1
Müller, M.2
Derendorf, H.3
-
43
-
-
0031952586
-
Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men
-
Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clinical Infectious Diseases 1998; 26: 1-12.
-
(1998)
Clinical Infectious Diseases
, vol.26
, pp. 1-12
-
-
Craig, W.A.1
-
44
-
-
0032838506
-
Evaluation of low-dose, extended-interval clindamycin regimens against Staphylococcus aureus and Streptococcus pneumoniae using a dynamic in vitro model of infection
-
Lewis RE, Klepser ME, Ernst EJ et al. Evaluation of low-dose, extended-interval clindamycin regimens against Staphylococcus aureus and Streptococcus pneumoniae using a dynamic in vitro model of infection. Antimicrobial Agents and Chemotherapy 1999; 43: 2005-9.
-
(1999)
Antimicrobial Agents and Chemotherapy
, vol.43
, pp. 2005-2009
-
-
Lewis, R.E.1
Klepser, M.E.2
Ernst, E.J.3
-
45
-
-
0030443051
-
Plasma disposition of clindamycin microbiological activity in cats after single oral doses of clindamycin hydrochloride as either capsules or aqueous solution
-
Boothe DM, Brown SA, Fate GD et al. Plasma disposition of clindamycin microbiological activity in cats after single oral doses of clindamycin hydrochloride as either capsules or aqueous solution. Journal of Veterinary Pharmacology and Therapeutics 1996; 19: 491-4.
-
(1996)
Journal of Veterinary Pharmacology and Therapeutics
, vol.19
, pp. 491-494
-
-
Boothe, D.M.1
Brown, S.A.2
Fate, G.D.3
-
47
-
-
19444385176
-
Molecular characterization of Staphylococcus intermedius carriage by healthy dogs and comparison of antimicrobial susceptibility patterns to isolates from dogs with pyoderma
-
Hartmann FA, White DG, West SE et al. Molecular characterization of Staphylococcus intermedius carriage by healthy dogs and comparison of antimicrobial susceptibility patterns to isolates from dogs with pyoderma. Veterinary Microbiology 2005; 108: 119-31.
-
(2005)
Veterinary Microbiology
, vol.108
, pp. 119-131
-
-
Hartmann, F.A.1
White, D.G.2
West, S.E.3
|